Horchata Emerges as the Next Beverage Trend Challenging Matcha and Bubble Tea in the UK Market Northland Reduces SoundHound AI Price Target to 12 Maintains Outperform Rating Amid Growth Investments Tottenham Hotspur Survival Could Serve as Foundation for Future Growth PepsiCo Prioritizes Hustle and Curiosity Over AI in Hiring as Tech Giants Automate Recruitment The Eye of the Storm How the WTOIMF Regulatory Gap May Fuel Currency Manipulation and Tariff Resurgence Senegals President Fires PM Dissolves Government Amid Deepening Debt Crisis PROG Holdings Q1 2026 Earnings Massive EPS Beat Drives Investor Caution Despite Strong Performance DLHC Q1 2026 Earnings EPS Misses Estimates Amidst Limited Revenue Disclosure Bowman Consulting Group Ltd Q1 2026 Earnings Significant EPS Miss Sends Mixed Signals Teekay Tankers Q1 2026 Earnings Strong EPS Beat Amidst Challenging Tanker Market AIV Q3 2024 Earnings EPS Misses Estimates as Company Reports Wider Loss iSpecimen Inc ISPC Q3 2024 Earnings Significant EPS Miss Amidst Operational Challenges Definium Therapeutics DFTX Gains Ground as Stock Approaches Key Resistance Level Cingulate Inc CING Plunges 17 as Selling Pressure Intensifies Power Solutions International PSIX Sees Slight Decline as Stock Tests Key Support Levels Tripcom Group TCOM Edges Higher Amid Steady Uptrend Key Levels in Focus BEPI Holds Steady Near Midpoint of Key Range Brookfield BRP Holdings Perpetual Notes Flat at 1562 CENT Q1 2026 Earnings EPS Surprises to the Upside Stock Moves Higher OCUL Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline BuzzFeed Inc BZFD Q1 2026 Earnings EPS Misses Estimates as Stock Surprises with Rally DARE Q1 2026 Earnings Narrowerthanexpected loss surprises as no revenue reported TMHC Q1 2026 Earnings EPS Surges Past Estimates by 2856 Nvidia Reports Another Blowout Quarter Revenue Surges 85 to 816 Billion in Fiscal Q1 BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 Sagimet Biosciences SGMT Inches Higher as Stock Tests Key Resistance at 748